Deferral of FDA consideration of enforcement discretion
MKTUPDTE
Wed, Aug 10 2022 09:48 am
The a2 Milk Company (a2MC, the Company) wishes to advise that earlier today it received notification from the US Food and Drug Administration (FDA) that, at this time, the FDA is deferring further consideration of the Company’s request for enforcement discretion to import infant milk formula (IMF) products into the US.
The Company has also subsequently been advised by the International Dairy Foods Association (IDFA) that equivalent letters have been sent to all pending enforcement discretion applicants, indicating that the FDA is deferring any further review at this time of all pending applications.
Authorised for release by
David Bortolussi
Managing Director and Chief Executive Officer
The a2 Milk Company Limited
Announcement PDF
Markets News
Markets
Market Close
NZ sharemarket falls 1.3% on uncertainty
The S&P/NZX 50 Index closed at 12,249.55, down 161.42 points or 1.3%.
Markets
Rocket Lab looks to raise up to US$500 million
The money will fund acquisitions and general corporate and working capital purposes.
Markets
The who’s who of NZME’s board hopefuls
Who are the players causing ripples in investor and media circles?
